Bristol-Myers Squibb Company
Hepatitis C virus inhibitors
Last updated:
Abstract:
The present disclosure relates to methods for making asunaprevir, useful treatment of Hepatitis C virus (HCV) infection, and its intermediates.
Status:
Grant
Type:
Utility
Filling date:
23 Jun 2015
Issue date:
3 Dec 2019